Predicting tumor response to TACE plus lenvatinib and PD-1 inhibitors for unresectable HCC: A multicenter observational study.

Saved in:
Bibliographic Details
Title: Predicting tumor response to TACE plus lenvatinib and PD-1 inhibitors for unresectable HCC: A multicenter observational study.
Authors: Deng LW; Department of Interventional Therapy, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China., Xie QY; Department of Hepatobiliary Surgery, the People's Hospital of Leshan, Leshan, China., Peng B; Department of Interventional Radiology, Chengdu Second People's Hospital, Chengdu, China., Zhao Y; Department of General Surgery, Chengdu Public Health Clinical Medical Center, Chengdu, China., Liu B; Department of Tumor Vascular Intervention, Chengdu Qingbaijiang District People's Hospital, Chengdu, China., Feng SF; Department of General Surgery, Chengdu Public Health Clinical Medical Center, Chengdu, China., Liu DX; Department of General Surgery, Chengdu Public Health Clinical Medical Center, Chengdu, China., Sun YY; Department of Interventional Therapy, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China., Wang HQ; Department of Hepatopancreatobiliary Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China., Liao CL; Department of Interventional Therapy, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China., Wang YL; Department of Interventional Therapy, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China., Liu JF; Department of Interventional Therapy, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China., Zhang C; Department of Radiology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China., Chen Y; Department of Pharmacy, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China., Xu GH; Department of Interventional Therapy, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China., Liu L; Department of Interventional Radiology, Chengdu Second People's Hospital, Chengdu, China., Cao L; Department of Tumor Vascular Intervention, Chengdu Qingbaijiang District People's Hospital, Chengdu, China. Electronic address: 327511253@qq.com., Wei G; Department of General Surgery, Chengdu Public Health Clinical Medical Center, Chengdu, China. Electronic address: weiguo69@sohu.com., Ren Y; Department of Interventional Radiology, Chengdu Second People's Hospital, Chengdu, China. Electronic address: ir_cd_2nd_ph@sina.com., Yang XG; Department of Interventional Therapy, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China. Electronic address: yanggangxue@163.com.
Source: European journal of radiology [Eur J Radiol] 2025 Nov; Vol. 192, pp. 112401. Date of Electronic Publication: 2025 Sep 01.
Publication Type: Journal Article; Multicenter Study; Observational Study
Journal Info: Publisher: Elsevier Science Ireland Ltd Country of Publication: Ireland NLM ID: 8106411 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7727 (Electronic) Linking ISSN: 0720048X NLM ISO Abbreviation: Eur J Radiol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1872-7727
DOI:10.1016/j.ejrad.2025.112401